Call 408.493.1800 | Fax 408.493.1801 | Toll Free 800.891.9699 (US Only) | Email: [email protected]

Anti-PD-L1 (Atezolizumab), Humanized Antibody

Monoclonal human IgG1 antibody against human PD-L1
Catalog #: A1305

Product Details

Cat # +Size A1305-100
Size 100 µg
Antibody Target PD-L1
Alternate Name Tecentriq, PD-L1
Antibody Type Monoclonal
Isotype Human IgG1
Immunogen Human programmed cell death 1 ligand 1 (PD-L1)
Accession # Q9NZQ7
Gene ID 29126
Appearance Colorless liquid
Formulation In phosphate buffered saline, pH 7.4
Purification Affinity purified
Species Reactivity Human
Application Neutralization, ELISA
Application & Usage Neutralization: 0.1-1 μg/ml, ELISA: 1 μg/ml
Handling The antibody solution should be gently mixed before use
Storage Conditions -20°C
Shipping Conditions Gel Pack
USAGE For Research Use Only! Not For Use in Humans.


Atezolizumab (Tecentriq) is a fully humanized, engineered monoclonal antibody of IgG1 isotype against the protein programmed cell death-ligand 1 (PD-L1). Atezolizumab blocks the interaction of PD-L1 with PD-1 and induces anti-tumor immune reactivation.

Why buy BioVision Products?
Global Presence
Technical Support
BioVision aims to provide our customers innovative tools for accelerating drug discovery and biological research. BioVision offers >8,000 products including the most comprehensive array of assay kits for key targets in Metabolic pathways.
BioVision is committed to providing the highest quality products at a competitive price.
We have a broad network of global distributors who are ready to address your research needs and ensure fast delivery.
Our highly trained Technical Support team provides comprehensive product support and is dedicated to resolving your issues quickly and efficiently.